Procter & Gamble Health Ltd (PGHL)
·Next Day Close·-0.16%·₹5,405.6
Key EventTrading window closure announced for PGHL directors and employees
Procter & Gamble Health Ltd (PGHL)
·Next Day Close·+0.08%·₹5,506.15
Key EventSEBI extended special window for re-lodging rejected transfer requests of physical shares until February 4, 2027.
ImpactShareholders with pending transfer requests from before April 1, 2019, can now re-lodge them by February 4, 2027, to benefit from the extended window.Sign up to read impact
Procter & Gamble Health Ltd (PGHL)
·Next Day Close·+0.28%·₹5,673.9
Key EventRe-appointment of S. Madhavan as Independent Director for five years effective November 15, 2026.
ImpactThis stabilizes governance and may boost investor confidence in long-term strategy.Sign up to read impact
Procter & Gamble Health Ltd (PGHL)
·Next Day Close·-1.81%·₹5,657.9
Key EventAGM passed resolutions including dividend declaration and director reappointment.
ImpactShareholders approved key financial and governance actions, signaling confidence in performance and leadership continuity.Sign up to read impact
Procter & Gamble Health Limited (PGHL)
·Next Day Close·-0.52%·₹5,922.4
Key Event59th AGM scheduled for September 3, 2026, featuring FY 2025-26 financial highlights and speaker registration until August 27, 2026
ImpactStrong financial performance with double-digit growth and significant dividend payout signals robust profitability and shareholder returnsSign up to read impact
Procter & Gamble Health Limited (PGHL)
·Next Day Close·+1.09%·₹6,030.35
Key EventRevised AGM record date to August 27, 2026
ImpactShareholders must hold shares by August 27, 2026, to qualify for the final dividend.Sign up to read impact
Procter & Gamble Health Limited (PGHL)
·Next Day Close·+1.01%·₹6,149.35
Key EventBoard approved unaudited Q3 FY2026 financial results
ImpactThe company reported higher quarterly profit but faces no immediate guidance on future performance.Sign up to read impact
Procter & Gamble Health Limited (PGHL)
·Next Day Close·+1.01%·₹6,149.35
Key EventQ1 FY2026 sales up 7% to ₹356 crores, PAT up 45% to ₹96 crores
ImpactStrong top-line and bottom-line growth signals healthy momentum and effective execution in the VMS segment.Sign up to read impact
Procter & Gamble Health Limited (PGHL)
·Next Day Close·-0.63%·₹6,321.4
Procter & Gamble Health Limited confirmed that securities dematerialized during the quarter ended June 30, 2026 were reported to BSE and NSE within the required timeframe under SEBI Regulation 74(5), as verified by Kfin Technologies Limited and enclosed documentation.
Sign up to read summaryProcter & Gamble Health Limited (PGHL)
·Next Day Close·+0.13%·₹6,248.75
Procter & Gamble Health Limited announced a recommended final dividend of Rs. 45 per equity share for FY 2025-26, subject to shareholder approval at the upcoming AGM. The dividend will be paid to shareholders listed in the register as of the AGM record date. To comply with TDS provisions under Section 194 of the Income Tax Act, the company requires shareholders to update tax residential status, PAN, and contact details via depositories or its RTA, Kfin Technologies. Resident shareholders must submit Form 121 to claim NIL TDS if eligible, while non-resident shareholders must provide PAN, Tax Residency Certificate, Form 41, and a self-declaration to claim DTAA benefits. TDS rates apply at 20% (plus surcharge and cess) for non-residents unless a lower DTAA rate is approved. Shareholders must submit all documents by August 12, 2026, to avoid higher TDS deductions.
Sign up to read summary